{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:18:31Z","timestamp":1787771911474,"version":"build-2784847793"},"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2015,12,3]],"date-time":"2015-12-03T00:00:00Z","timestamp":1449100800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0144103","type":"journal-article","created":{"date-parts":[[2015,12,3]],"date-time":"2015-12-03T18:42:49Z","timestamp":1449168169000},"page":"e0144103","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":19,"title":["Antimicrobial Non-Susceptibility of Escherichia coli from Outpatients and Patients Visiting Emergency Rooms in Taiwan"],"prefix":"10.1371","volume":"10","author":[{"given":"Jann-Tay","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan-Chwen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Yee","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Phone","family":"Fung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-Ching","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Shen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yih-Ru","family":"Shiau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Chen","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jui-Fen","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Wen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsai-Ling","family":"Yang Lauderdale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,12,3]]},"reference":[{"issue":"2","key":"ref1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrmicro818","article-title":"Pathogenic <italic>Escherichia coli<\/italic>","volume":"2","author":"JB Kaper","year":"2004","journal-title":"Nat Rev Microbiol"},{"issue":"12","key":"ref2","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nrurol.2010.190","article-title":"The epidemiology of urinary tract infection","volume":"7","author":"B Foxman","year":"2010","journal-title":"Nat Rev Urol"},{"key":"ref3","unstructured":"WHO. Technical consultation: strategies for global surveillance of antimicrobial resistance. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/apps.who.int\/iris\/bitstream\/10665\/90975\/1\/WHO_HSE_PED_2013.10358_eng.pdf\" xlink:type=\"simple\">http:\/\/apps.who.int\/iris\/bitstream\/10665\/90975\/1\/WHO_HSE_PED_2013.10358_eng.pdf<\/ext-link>. (2 March 2015, date last accessed).2013. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/apps.who.int\/iris\/bitstream\/10665\/90975\/1\/WHO_HSE_PED_2013.10358_eng.pdf\" xlink:type=\"simple\">http:\/\/apps.who.int\/iris\/bitstream\/10665\/90975\/1\/WHO_HSE_PED_2013.10358_eng.pdf<\/ext-link>."},{"issue":"7","key":"ref4","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.amjmed.2003.07.005","article-title":"Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis","volume":"115","author":"S Harbarth","year":"2003","journal-title":"Am J Med"},{"issue":"11","key":"ref5","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1056\/NEJMcp1104429","article-title":"Clinical practice. Uncomplicated urinary tract infection","volume":"366","author":"TM Hooton","year":"2012","journal-title":"N Engl J Med"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1086\/649554","article-title":"Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America","volume":"50","author":"JS Solomkin","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"8","key":"ref7","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1093\/jac\/dkv157","article-title":"Reviving old antibiotics","volume":"70","author":"U Theuretzbacher","year":"2015","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"ref8","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.clinthera.2013.03.022","article-title":"Antimicrobial susceptibility of inpatient urinary tract isolates of gram-negative bacilli in the United States: results from the study for monitoring antimicrobial resistance trends (SMART) program: 2009\u20132011","volume":"35","author":"SK Bouchillon","year":"2013","journal-title":"Clin Ther"},{"issue":"12","key":"ref9","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1093\/jac\/dku282","article-title":"Nitrofurantoin retains antimicrobial activity against multidrug-resistant urinary <italic>Escherichia coli<\/italic> from US outpatients","volume":"69","author":"GV Sanchez","year":"2014","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"ref10","doi-asserted-by":"crossref","first-page":"6235","DOI":"10.3390\/ijerph10126235","article-title":"<italic>Escherichia coli<\/italic> in Europe: an overview","volume":"10","author":"N Allocati","year":"2013","journal-title":"Int J Environ Res Public Health"},{"issue":"10","key":"ref11","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1128\/AAC.00877-08","article-title":"Surveillance of community-based reservoirs reveals the presence of CTX-M, imported AmpC, and OXA-30 \u03b2-lactamases in urine isolates of <italic>Klebsiella pneumoniae<\/italic> and <italic>Escherichia coli<\/italic> in a U.S. community","volume":"52","author":"ND Hanson","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"ref12","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/jac\/dkt500","article-title":"Proportion of extended-spectrum \u03b2-lactamase (ESBL)-producing isolates among Enterobacteriaceae in Africa: evaluation of the evidence\u2014systematic review","volume":"69","author":"GS Tansarli","year":"2014","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2174\/138161213804070348","article-title":"Enterobacteriaceae that produce extended-spectrum \u03b2-lactamases and AmpC \u03b2-lactamases in the community: the tip of the iceberg?","volume":"19","author":"JD Pitout","year":"2013","journal-title":"Curr Pharm Des"},{"issue":"6","key":"ref14","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ijantimicag.2013.02.022","article-title":"Antimicrobial susceptibility of gram-negative and gram-positive bacteria collected from countries in Eastern Europe: results from the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) 2004\u20132010","volume":"41","author":"A Balode","year":"2013","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"ref15","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/jac\/dku468","article-title":"Epidemiology and risk factors for infections due to AmpC \u03b2-lactamase-producing <italic>Escherichia coli<\/italic>","volume":"70","author":"V Pascual","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1186\/s12879-014-0659-0","article-title":"Nationwide high prevalence of CTX-M and an increase of CTX-M-55 in <italic>Escherichia coli<\/italic> isolated from patients with community-onset infections in Chinese county hospitals","volume":"14","author":"J Zhang","year":"2014","journal-title":"BMC Infect Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"74","DOI":"10.2174\/1874285801206010074","article-title":"Fluoroquinolone resistance among gram-negative urinary tract pathogens: global SMART program results, 2009\u20132010","volume":"6","author":"S Bouchillon","year":"2012","journal-title":"Open Microbiol J"},{"key":"ref18","unstructured":"European Center for Disease Prevention and Control. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/ecdc.europa.eu\/en\/healthtopics\/antimicrobial_resistance\/database\/Pages\/graph_reports.aspx\" xlink:type=\"simple\">http:\/\/ecdc.europa.eu\/en\/healthtopics\/antimicrobial_resistance\/database\/Pages\/graph_reports.aspx<\/ext-link>. European Center for Disease Prevention and Control. 2015."},{"issue":"6","key":"ref19","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1093\/jac\/dkv043","article-title":"Surveillance of antibiotic susceptibility of urinary tract pathogens for a population of 5.6 million over 4 years","volume":"70","author":"D Ironmonger","year":"2015","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ijantimicag.2011.09.013","article-title":"Antimicrobial susceptibility of <italic>Escherichia coli<\/italic> from community-acquired urinary tract infections in Europe: the ECO.SENS study revisited","volume":"39","author":"G Kahlmeter","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"ref21","article-title":"Performance Standards for Antimicrobial Susceptibility Testing: 24<sup>th<\/sup> Informational Supplement M100-S24","year":"2014"},{"issue":"8","key":"ref22","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.3201\/eid2008.140341","article-title":"Levofloxacin-resistant <italic>Haemophilus influenzae<\/italic>, Taiwan, 2004\u20132010","volume":"20","author":"SC Kuo","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1186\/1471-2334-14-486","article-title":"Antimicrobial susceptibilities of <italic>Proteus mirabilis<\/italic>: a longitudinal nationwide study from the Taiwan surveillance of antimicrobial resistance (TSAR) program","volume":"14","author":"JT Wang","year":"2014","journal-title":"BMC Infect Dis"},{"key":"ref24","article-title":"Abbreviated Identification of Bacteria and Yeast; Approved Guideline\u2014Second Edition M35-A2","year":"2008"},{"issue":"6","key":"ref25","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1128\/JCM.18.6.1287-1291.1983","article-title":"Rapid and economical identification and antimicrobial susceptibility test methodology for urinary tract pathogens","volume":"18","author":"SC Edberg","year":"1983","journal-title":"J Clin Microbiol"},{"issue":"12","key":"ref26","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1111\/j.1600-0463.2007.00722.x","article-title":"Multiplex PCR amplification assay for the detection of <italic>bla<\/italic><sub>SHV<\/sub>, <italic>bla<\/italic><sub>TEM<\/sub> and <italic>bla<\/italic><sub>CTX-M<\/sub> genes in Enterobacteriaceae","volume":"115","author":"HJ Monstein","year":"2007","journal-title":"APMIS"},{"issue":"6","key":"ref27","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1128\/JCM.40.6.2153-2162.2002","article-title":"Detection of plasmid-mediated AmpC \u03b2-lactamase genes in clinical isolates by using multiplex PCR","volume":"40","author":"FJ Perez-Perez","year":"2002","journal-title":"J Clin Microbiol"},{"issue":"3","key":"ref28","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1128\/CMR.00001-07","article-title":"Carbapenemases: the versatile \u03b2-lactamases","volume":"20","author":"AM Queenan","year":"2007","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"ref29","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1128\/CMR.00021-10","article-title":"Integrated multilevel surveillance of the world&apos;s infecting microbes and their resistance to antimicrobial agents","volume":"24","author":"TF O'Brien","year":"2011","journal-title":"Clin Microbiol Rev"},{"issue":"11","key":"ref30","doi-asserted-by":"crossref","first-page":"5600","DOI":"10.1128\/AAC.01485-13","article-title":"In vitro activity of ceftaroline-avibactam against gram-negative and gram-positive pathogens isolated from patients in Canadian hospitals from 2010 to 2012: results from the CANWARD surveillance study","volume":"57","author":"JA Karlowsky","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"ref31","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/QCO.0b013e3283398dc1","article-title":"Extended-spectrum \u03b2-lactamase producing <italic>Escherichia coli<\/italic>: changing epidemiology and clinical impact","volume":"23","author":"J Oteo","year":"2010","journal-title":"Curr Opin Infect Dis"},{"key":"ref32","article-title":"Overview of ESBL-producing Enterobacteriaceae from a Nordic perspective","volume":"4","author":"A Brolund","year":"2014","journal-title":"Infect Ecol Epidemiol"},{"issue":"4","key":"ref33","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/jac\/dks464","article-title":"National multidrug-resistant bacteria (MDRB) surveillance in France through the RAISIN network: a 9 year experience","volume":"68","author":"A Carbonne","year":"2013","journal-title":"J Antimicrob Chemother"},{"issue":"6\u20137","key":"ref34","first-page":"305","article-title":"CTX-M-type \u03b2-lactamases: a successful story of antibiotic resistance","volume":"303","author":"MM D'Andrea","year":"2013","journal-title":"Int J Med Microbiol"},{"issue":"Suppl 1","key":"ref35","doi-asserted-by":"crossref","first-page":"i3","DOI":"10.1093\/jac\/dkp256","article-title":"The changing epidemiology of resistance","volume":"64","author":"PM Hawkey","year":"2009","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"ref36","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1128\/AAC.00971-12","article-title":"Distribution of extended-spectrum \u03b2-lactamases, AmpC \u03b2-lactamases, and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal infections in the Asia-Pacific region: results of the study for Monitoring Antimicrobial Resistance Trends (SMART)","volume":"57","author":"WH Sheng","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"ref37","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1093\/cid\/cit017","article-title":"Background and rationale for revised clinical and laboratory standards institute interpretive criteria (Breakpoints) for Enterobacteriaceae and <italic>Pseudomonas aeruginosa<\/italic>: I. Cephalosporins and Aztreonam","volume":"56","author":"MN Dudley","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"3","key":"ref38","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ijantimicag.2010.05.012","article-title":"Comparison of CLSI 2009, CLSI 2010 and EUCAST cephalosporin clinical breakpoints in recent clinical isolates of <italic>Escherichia coli<\/italic>, <italic>Klebsiella pneumoniae<\/italic> and <italic>Klebsiella oxytoca<\/italic> from the SMART Global Surveillance Study","volume":"36","author":"SP Hawser","year":"2010","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"ref39","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.diagmicrobio.2011.03.008","article-title":"Improved detection of AmpC \u03b2-lactamases in <italic>Escherichia coli<\/italic>, <italic>Klebsiella pneumoniae<\/italic>, and <italic>Proteus mirabilis<\/italic> using new susceptibility breakpoints for third-generation cephalosporins","volume":"70","author":"TY Tan","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"Suppl 1","key":"ref40","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1469-0691.2007.01867.x","article-title":"The spread of CTX-M-type extended-spectrum \u03b2-lactamases","volume":"14","author":"GM Rossolini","year":"2008","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"ref41","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1128\/JCM.03361-13","article-title":"Modified CLSI extended-spectrum \u03b2-lactamase (ESBL) confirmatory test for phenotypic detection of ESBLs among Enterobacteriaceae producing various \u03b2-lactamases","volume":"52","author":"A Poulou","year":"2014","journal-title":"J Clin Microbiol"},{"issue":"5","key":"ref42","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1086\/604713","article-title":"A multinational survey of risk factors for infection with extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae in nonhospitalized patients","volume":"49","author":"R Ben-Ami","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"3","key":"ref43","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jmii.2013.08.010","article-title":"Risk factors of community-onset urinary tract infections caused by plasmid-mediated AmpC \u03b2-lactamase-producing Enterobacteriaceae","volume":"48","author":"CH Lee","year":"2015","journal-title":"J Microbiol Immunol Infect"},{"issue":"3","key":"ref44","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/jac\/dkp220","article-title":"Nursing homes as a reservoir of extended-spectrum \u03b2-lactamase (ESBL)-producing ciprofloxacin-resistant <italic>Escherichia coli<\/italic>","volume":"64","author":"PJ Rooney","year":"2009","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"ref45","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1128\/AAC.45.11.3084-3091.2001","article-title":"Emergence of reduced susceptibility and resistance to fluoroquinolones in <italic>Escherichia coli<\/italic> in Taiwan and contributions of distinct selective pressures","volume":"45","author":"LC McDonald","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 2","key":"ref46","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2165\/00003495-199958002-00003","article-title":"Mechanisms of fluoroquinolone resistance: an update 1994\u20131998","volume":"58","author":"LJ Piddock","year":"1999","journal-title":"Drugs"},{"issue":"4","key":"ref47","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1128\/CMR.00016-09","article-title":"Plasmid-mediated quinolone resistance: a multifaceted threat","volume":"22","author":"J Strahilevitz","year":"2009","journal-title":"Clin Microbiol Rev"},{"issue":"21","key":"ref48","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.2146\/ajhp110464","article-title":"Declining susceptibilities of gram-negative bacteria to the fluoroquinolones: effects on pharmacokinetics, pharmacodynamics, and clinical outcomes","volume":"69","author":"MJ Labreche","year":"2012","journal-title":"Am J Health Syst Pharm"},{"issue":"4","key":"ref49","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1128\/AAC.50.4.1525-1527.2006","article-title":"In vivo selection of fluoroquinolone-resistant <italic>Escherichia coli<\/italic> isolates expressing plasmid-mediated quinolone resistance and expanded-spectrum \u03b2-lactamase","volume":"50","author":"L Poirel","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"ref50","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1378\/chest.123.5.1615","article-title":"Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival","volume":"123","author":"J Valles","year":"2003","journal-title":"Chest"},{"issue":"4","key":"ref51","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","article-title":"Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia","volume":"171","year":"2005","journal-title":"Am J Respir Crit Care Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0144103","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,28]],"date-time":"2022-05-28T04:58:17Z","timestamp":1653713897000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0144103"}},"subtitle":[],"editor":[{"given":"Jose","family":"Melo-Cristino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,12,3]]},"references-count":51,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2015,12,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0144103","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,3]]}}}